HealthCore-Anthem Research Network Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2016
NCT02697916
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Anthem, Inc | Anthem Strong Families | Healthcore | HealthCore-NERI

Active Ingredients

Drugs in Phase 4 Trials (2)

olodaterol (striverdi respimat) (1 trial)

tiotropium (spiriva) (1 trial)

Drugs in Other Trials (1)

acetylsalicylic acid (aspirin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lung Diseases (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3